Imugene Limited
Imugene Limited, a clinical-stage immuno-oncology company, develops a range of immunotherapies to activate the immune system of cancer patients to treat and eradicate tumours in Australia. Its lead products under development azer-cel, an allogeneic CAR T cell therapy in phase 1 clinical trial targeting relapsed/refractory non-hodgkin lymphoma and b-cell acute lymphoblastic leukemia; CF33 VAXINIA,… Read more
Imugene Limited (IUGNF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: -0.820x
Based on the latest financial reports, Imugene Limited (IUGNF) has a cash flow conversion efficiency ratio of -0.820x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-36.95 Million) by net assets ($45.03 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Imugene Limited - Cash Flow Conversion Efficiency Trend (1993–2025)
This chart illustrates how Imugene Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Imugene Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Imugene Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Union Dental Holdings Inc
OTCQB:XCRT
|
0.032x |
|
Star Fashion Culture Holdings Limited
NASDAQ:STFS
|
-0.479x |
|
Arkle Resources PLC
STU:48O
|
-0.027x |
|
Thunder Bridge Capital Partners IV Inc. Warrant
NASDAQ:THCPW
|
-0.004x |
|
Terrain Minerals Ltd
AU:TMX
|
-0.113x |
|
Castle Peak Holdings Public Company Limited
BK:CPH
|
0.078x |
|
Plaza Centers NV
WAR:PLZ
|
0.001x |
|
Vaishali Pharma Limited
NSE:VAISHALI
|
0.030x |
Annual Cash Flow Conversion Efficiency for Imugene Limited (1993–2025)
The table below shows the annual cash flow conversion efficiency of Imugene Limited from 1993 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | $45.03 Million | $-75.57 Million | -1.678x | -95.07% |
| 2024-06-30 | $118.25 Million | $-101.73 Million | -0.860x | -447.78% |
| 2023-06-30 | $189.63 Million | $-29.78 Million | -0.157x | +28.98% |
| 2022-06-30 | $138.70 Million | $-30.67 Million | -0.221x | -9.50% |
| 2021-06-30 | $65.02 Million | $-13.13 Million | -0.202x | -19.19% |
| 2020-06-30 | $59.81 Million | $-10.13 Million | -0.169x | +41.54% |
| 2019-06-30 | $27.29 Million | $-7.91 Million | -0.290x | +0.52% |
| 2018-06-30 | $15.48 Million | $-4.51 Million | -0.291x | -24.18% |
| 2017-06-30 | $11.39 Million | $-2.67 Million | -0.235x | +39.56% |
| 2016-06-30 | $7.86 Million | $-3.05 Million | -0.388x | -46.86% |
| 2015-06-30 | $7.73 Million | $-2.04 Million | -0.264x | -55.52% |
| 2014-06-30 | $6.73 Million | $-1.14 Million | -0.170x | +76.58% |
| 2013-06-30 | $1.89 Million | $-1.37 Million | -0.726x | +19.38% |
| 2012-06-30 | $1.07 Million | $-965.92K | -0.900x | -447.17% |
| 2011-06-30 | $4.21 Million | $1.09 Million | 0.259x | +156.39% |
| 2010-06-30 | $3.79 Million | $-1.74 Million | -0.460x | -377.67% |
| 2009-06-30 | $5.33 Million | $881.77K | 0.166x | +160.74% |
| 2008-06-30 | $4.67 Million | $-1.27 Million | -0.273x | +24.77% |
| 2007-06-30 | $4.70 Million | $-1.70 Million | -0.362x | -27.73% |
| 2006-06-30 | $6.46 Million | $-1.83 Million | -0.284x | -50.67% |
| 2005-06-30 | $8.65 Million | $-1.63 Million | -0.188x | +32.68% |
| 2004-06-30 | $5.43 Million | $-1.52 Million | -0.280x | +71.84% |
| 2002-06-30 | $792.83K | $-787.36K | -0.993x | -108.81% |
| 2001-06-30 | $-226.54K | $-2.55 Million | 11.266x | +892.20% |
| 2000-06-30 | $2.78 Million | $-3.95 Million | -1.422x | -392.70% |
| 1997-06-30 | $7.45 Million | $-2.15 Million | -0.289x | -16.06% |
| 1996-06-30 | $8.12 Million | $-2.02 Million | -0.249x | -58.27% |
| 1995-06-30 | $10.62 Million | $-1.67 Million | -0.157x | -20.81% |
| 1994-06-30 | $11.19 Million | $-1.46 Million | -0.130x | -235.76% |
| 1993-06-30 | $5.11 Million | $-198.00K | -0.039x | -- |